Search results for "risk factors."

showing 10 items of 3749 documents

Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?

2019

Abstract Background Although lipid-lowering drugs, especially statins, and recently also PCSK9 inhibitors can reduce LDL cholesterol (LDL-C) and decrease the risk for cardiovascular disease (CVD) including coronary artery disease (CAD) events most efficiently, only 5–10% of high-risk cardiovascular patients reach the target values recommended by international guidelines. In patients who cannot be treated adequately by drugs it is possible to reduce increased LDL-C and/or lipoprotein(a) (Lp(a)) values by the use of lipoprotein apheresis (LA) with the potential to decrease severe CVD events in the range of 70%->80%. Even in Germany, a country with well-established reimbursement guidelines for…

medicine.medical_specialtyHyperlipoproteinemiasReferralPopulationDisease030204 cardiovascular system & hematologyRisk AssessmentHealth Services AccessibilityCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal MedicinemedicineHumans030212 general & internal medicineIntensive care medicineeducationCompetence (human resources)Reimbursementeducation.field_of_studybusiness.industryPatient SelectionGeneral MedicineCholesterol LDLmedicine.diseaseCardiovascular DiseasesBlood Component RemovalPatient ComplianceLipid loweringCardiology and Cardiovascular MedicinebusinessLipoprotein apheresisBiomarkersLipoprotein(a)Atherosclerosis. Supplements
researchProduct

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease--Additional particular aspects of the Pro(a)LiFe multice…

2015

Lipoprotein apheresis (LA) can lower LDL-cholesterol and Lp(a) by 60%-70% and is the final escalating option in patients with hyperlipoproteinemias involving LDL or Lp(a) particles. Major therapeutic effect of LA is preventing cardiovascular events. In Germany since 2008 a reimbursement guideline has been implemented accepting to establish the indication for LA not only for familial or severe forms of hypercholesterolemia but also based on Lp(a)-hyperlipoproteinemia associated with a progressive course of cardiovascular disease, that persists despite effective treatment of other concomitant cardiovascular risk factors. The Pro(a)LiFe-study confirmed with a prospective multicenter design tha…

medicine.medical_specialtyHyperlipoproteinemiasTime FactorsDiseaseRisk AssessmentCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicineMulticenter trialGermanyInternal MedicinemedicineHumansProspective StudiesFamily historyRetrospective Studiesbiologybusiness.industryTherapeutic effectGeneral MedicineGuidelineLipoprotein(a)medicine.diseaseSurgeryTreatment OutcomeCardiovascular Diseasesbiology.proteinCardiologyBlood Component RemovalDisease ProgressionCardiology and Cardiovascular MedicineRisk assessmentbusinessBiomarkersLipoprotein(a)Atherosclerosis. Supplements
researchProduct

Control of arterial hypertension in Spain

2011

Hypertension is a leading global risk factor for the burden of cardiovascular disease. Data about changes in hypertension control are important to set intervention priorities. We conducted a systematic review and meta-analysis of epidemiological studies to determine the control of hypertension in Spain over the past decade.A search of PubMed/MEDLINE, SCOPUS and IME was performed for epidemiological studies conducted in Spain (since 2000) with data on control rates for hypertension. The primary outcome was the prevalence of uncontrolled hypertension defined as the percentage of patients having SBP at least 140 mmHg and/or DBP at least 90 mmHg. For populations at risk (e.g. patients with diab…

medicine.medical_specialtyHypertension controlPhysiologybusiness.industryMEDLINEDiseaseRisk FactorsSpainMeta-analysisHypertensionEpidemiologyPrevalenceInternal MedicinemedicinePhysical therapyHumansCardiology and Cardiovascular MedicineIntensive care medicinebusinessGlobal riskJournal of Hypertension
researchProduct

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism

2018

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but feared long-term complication of acute pulmonary embolism (PE), although CTEPH may occur in patients with no history of symptomatic venous thromboembolism. It represents the most severe presentation of the so-called 'post-PE syndrome', a phenomenon of permanent functional limitations after PE caused by deconditioning after PE or ventilatory or circulatory impairment as a result of unresolved pulmonary artery thrombi. Because the post-PE syndrome may occur in up to 50% of PE survivors, and CTEPH tends to have an insidious and non-specific clinical presentation, CTEPH is often not diagnosed or diagnosed after a very long dela…

medicine.medical_specialtyHypertension Pulmonarymedicine.medical_treatmentHemodynamicsEndarterectomyPulmonary Artery030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsAngioplastyInternal medicinemedicine.arterymedicineHumansArterial PressureBlood CoagulationAntihypertensive Agentsbusiness.industryAnticoagulantsHematologymedicine.diseasePulmonary hypertensionPulmonary embolismTreatment Outcomemedicine.anatomical_structure030228 respiratory systemChronic DiseaseCirculatory systemPulmonary arteryCardiologyVascular resistancePulmonary EmbolismbusinessComplicationAngioplasty BalloonJournal of Thrombosis and Haemostasis
researchProduct

Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis…

2022

Abstract Although each autoimmune disease is associated with specific tissue or organ damage, rheumatic diseases share a pro-inflammatory pattern that might increase cardiovascular risk. Retrospective and prospective studies on patients affected by systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) highlighted the concept of “accelerated atherosclerosis”. Therefore, the purpose of this systematic review and meta-analysis is the assessment of symptomatic or asymptomatic cardiovascular events among patients with rheumatic diseases as RA and SLE. The literature research obtained all manuscripts published in the English language between 2015 and 2019 for a total of 2355 manuscript…

medicine.medical_specialtyImmunologyDiseaseAsymptomaticArthritis RheumatoidRisk FactorsInternal medicinemedicineHumansLupus Erythematosus SystemicImmunology and AllergyProspective StudiesProspective cohort studyRetrospective StudiesAutoimmune diseasebusiness.industryIncidence (epidemiology)medicine.diseaseCardiovascular DiseasesHeart Disease Risk FactorsAge Cardiovascular events Metaanalysis Rheumatoid arthritis Risk Systemic lupus erythematosusMeta-analysisRheumatoid arthritisInclusion and exclusion criteriamedicine.symptombusinessAutoimmunity Reviews
researchProduct

The Dietary Inflammatory Index and asthma burden in children: A latent class analysis

2021

Introduction: Unbalanced dietary intake has been increasingly recognized as an important modifiable risk factor for asthma. In this study, we assessed whether a pro-inflammatory diet is associated with higher asthma burden in three steps: (1) identification of asthma latent classes (LC) based on symptoms, indoor exposures, and pulmonary function; (2) identification of risk factors associated with LC membership; and (3) estimation of the probabilities of LC membership with variation in DII. Methods: A cross-sectional study on 415 children aged 5–14 years (266 with persistent asthma and 149 controls). LC analysis was performed in asthmatic children. The DII was calculated based on a semiquant…

medicine.medical_specialtyImmunologyLogistic regressionArticlePulmonary function testingburdenchildrenRisk FactorsInternal medicinelatent class analysisHumansImmunology and AllergyMedicineRisk factorDisease burdenLung functionAsthmaInflammationbusiness.industryindoor exposuresSymptom burdenlung functionasthmamedicine.diseaseLatent class modelasthma burden children dietary inflammatory index indoor exposures latent class analysis lung functionCross-Sectional StudiesPediatrics Perinatology and Child Healthdietary inflammatory indexbusinessdiet
researchProduct

Perioperative chemotherapy versus surgery alone for resectable colorectal liver metastases: an international multicentre propensity score matched ana…

2021

Abstract Background There is still uncertainty regarding the role of perioperative chemotherapy (CTx) in patients with resectable colorectal liver metastases (CRLM), especially in those with a low-risk of recurrence. Methods Multicentre retrospective analysis of patients with CRLM undergoing liver resection between 2010–2015. Patients were divided into two groups according to whether they received perioperative CTx or not and were compared using propensity score matching (PSM) analysis. Then, they were stratified according to prognostic risk scores, including: Clinical Risk Score (CRS), Tumour Burden Score (TBS) and Genetic And Morphological Evaluation (GAME) score. Results The study includ…

medicine.medical_specialtyIndependent predictorResection03 medical and health sciences0302 clinical medicineRisk FactorsPerioperative chemotherapyLong term outcomesmedicineOverall survivalHepatectomyHumansPropensity ScoreRetrospective StudiesHepatologybusiness.industryLiver NeoplasmsGastroenterologyPerioperativePrognosisSurgery030220 oncology & carcinogenesisPropensity score matching030211 gastroenterology & hepatologyNeoplasm Recurrence LocalColorectal NeoplasmsbusinessClinical risk factorHPB
researchProduct

An update on the role of markers of inflammation in atherosclerosis

2009

In recent years, several studies have used the measurement of carotid intima-media thickness (IMT) as a marker of early atherosclerosis: IMT has been shown to correlate significantly with the presence of coronary artery disease (CAD) and to predict fatal and not fatal cerebro- and cardio-vascular events. These findings highlight the importance of recognizing and managing early stages of atherosclerosis for effective cardiovascular prevention. Beyond traditional established cardiovascular risk factors, inflammation has been shown to be crucial throughout atherosclerosis from endothelial dysfunction to plaque rupture and thrombosis. Several studies have shown the existence of a strong relatio…

medicine.medical_specialtyInflammationFibrinogenatherosclerosismarkersPathogenesisCoronary artery diseaseinflammation atherosclerosis cardiovascular riskRisk FactorsInternal medicineInternal MedicineMedicineHumanscardiovascular diseasesEndothelial dysfunctionSubclinical infectionbusiness.industryIncidence (epidemiology)Biochemistry (medical)medicine.diseaseAtherosclerosisThrombosisCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drug
researchProduct

Prevalence, New Incidence, Course, and Risk Factors of PTSD, Depression, Anxiety, and Panic Disorder during the Covid-19 Pandemic in 11 Countries

2021

We aimed to evaluate the prevalence and incidence of post-traumatic stress disorder (PTSD), depression, anxiety, and panic disorder (PD) among citizens in 11 countries during the Covid-19 pandemic. We explored risks and protective factors most associated with the development of these mental health disorders and their course at 68 days follow up. We acquired 9543 unique responses via an online survey that was disseminated in UK, Belgium, Netherlands, Bulgaria, Czech Republic, Finland, India, Latvia, Poland, Romania, and Sweden. The prevalence and new incidence during the pandemic for at least one disorder was 48.6% and 17.6%, with the new incidence of PTSD, anxiety, depression, and panic dis…

medicine.medical_specialtyLeadership and Managementmultinational studyPopulationHealth Informaticsgeneral populationArticle03 medical and health sciences0302 clinical medicineHealth Information ManagementMedicinerisk factors030212 general & internal medicinepanic disorderPsychiatryeducationresilienceDepression (differential diagnoses)education.field_of_studybusiness.industryHealth PolicyPanic disorderPublic healthIncidence (epidemiology)pandemicRPublic Health Global Health Social Medicine and EpidemiologyPTSDmedicine.diseaseanxietyMental health030227 psychiatryFolkhälsovetenskap global hälsa socialmedicin och epidemiologidepressionAnxietyMedicineMental healthmedicine.symptombusinessCovid-19Psychosocialmental healthHealthcare
researchProduct

Non-alcoholic fatty liver disease pathogenesis: The present and the future

2008

Non-alcoholic fatty liver disease is the clinical hepatic expression of metabolic syndrome. The prevalence of non-alcoholic fatty liver disease is around 20-30%, and with a rapid increase in the metabolic risk factors in the general population, non-alcoholic fatty liver disease has become the most common cause of liver disease worldwide. A fraction (20-30%) of non-alcoholic fatty liver disease patients develop a potentially progressive hepatic disorder, namely non-alcoholic steatohepatitis, leading to end-stage liver disease. The pathogenesis of non-alcoholic fatty liver disease is not entirely understood, and even if insulin resistance is a major pathogenetic key, many other factors are im…

medicine.medical_specialtyLipolysisPopulationPhysiologyApoptosisMitochondria LiverInsulin resistance Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis SteatosisDiseaseFatty Acids NonesterifiedPathogenesisLiver diseaseInsulin resistanceAdipokinesRisk FactorsInternal medicinemedicineAnimalsHumansGenetic Predisposition to Diseaseeducationeducation.field_of_studyHepatologybusiness.industryFatty liverGastroenterologymedicine.diseaseDietFatty LiverOxidative StressEndocrinologyAdipose TissueLiverDisease ProgressionHepatocytesCytokinesInsulin ResistanceSteatohepatitisMetabolic syndromebusinessDigestive and Liver Disease
researchProduct